An hour may change everything for patients with lumbar spinal stenosis (LSS). Find out how this minimally invasive, outpatient procedure, which has a safety profile similar to an epidural steroid injection (ESI), may help you stand longer and walk farther with less pain.
Learn MoreAbout mild for Patients
Pain or numbness in lower back when standing
Pain, numbness or tingling in legs or buttocks when walking
Relief when sitting or leaning forward
Help your LSS patients, even those with comorbidities, by removing a major root cause of their neurogenic claudication. Move to mild® to provide patients with long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results. Learn more about the minimally invasive mild® Procedure’s key benefits, clinical outcomes and how it can be incorporated into your treatment algorithm.
Learn MoreAbout mild for Healthcare Professionals
In honor of #PainAwarenessMonth, we’re reflecting on how #LSS impacts patients and how we can help improve their quality of life.
With the Mild Procedure, we empower Interventional Pain Management (IPM) providers with a minimally invasive treatment for LSS to deliver an enhanced patient experience and expand access for patients looking for relief.
Visit the 🔗 in bio to learn how we’re working to elevate LSS patients and their providers.
Recently, we’ve been talking with physicians and APPs around the nation about how the Mild Procedure can elevate their practices.
We’re sharing how Mild is impacting the entire IPM community by enhancing patient experience, expanding patient access, and empowering practice growth.
Interested in how Mild can elevate your practice and patients? Go to 🔗 link in bio to learn more.
By joining the Mild360 Fellows Enrichment Program, interventional pain fellows gain access to a wide range of training opportunities, including performing the Mild Procedure, reading MRIs, reimbursement, patient outreach, and more.
With opportunities for live peer-to-peer and mentor engagement, Mild360 allows participants to advance their knowledge of treatment options for chronic low back pain (CLBP) caused by lumbar spinal stenosis (#LSS).
Jumpstart your career and enroll today at the 🔗 link in bio.
Since implementing the Mild Procedure to help treat #LSS, Dr. Sushanth Boda (@doc.painrelief) has seen phenomenal improvements in patient experience:
“From a physician’s perspective, it’s awesome to hear those stories that they relay back to us, to really see the impact that we can have for these patients.”
Want to learn how Dr. Boda is enhancing patient experience and growing his practice? Visit the 🔗 link in bio to learn how.
The Mild360 Fellows Enrichment Program is a valuable opportunity for interventional pain fellows nationwide. Live virtual sessions offer peer-to-peer and thought leader engagement from both a clinical and practical perspective.
By joining Mild360, you’ll gain the tools and experience you need to position yourself as a leader in the field of interventional pain management, particularly for managing chronic low back pain (CLBP) caused by lumbar spinal stenosis (#LSS).
Enroll today at the 🔗 link in bio.
In case you missed it, the Medical Sales Accelerator Podcast welcomed Our VP of Sales, Kris Krustangel (@kriskrustangel), for a conversation on how he fosters authenticity and prioritizes value delivery to cultivate high performing teams.
As a leader, Kris always encourages his team and colleagues to invest in themselves, in their energy and mindset, so that they can continue doing the hard work and making an impact.
To hear Kris’s perspective on leadership, check out podcast at the 🔗 link in bio.
We had a fantastic time at #ASPN2024! To all our providers, thank you for celebrating over 100,000 patients treated with Mild, sharing your stories, and engaging in discussions on how we can partner with you to further elevate your practices.
Check out a highlight reel of our favorite moments, and go to the 🔗 link in bio to learn how Mild is elevating the IPM community.
Join us in welcoming the newest members of #TeamVertos!
We are proud to present District Sales Managers, Zack Aronson, Douglas Baca, Ian Hauck, Channing Middleton, Amanda Sammons, David Schoonhoven, and Jeff Souza.
We are excited to see our company continue to grow!
Interested in joining our team? Click the 🔗 link in bio for employment opportunities.
Dr. Sherif Costandi recently released data from the MOTION Study at #ASPN2024.
The new data showed that conventional medical management (CMM) patients who crossed over to Mild had comparable improvements in functional outcomes as the patients in the original Mild+CMM treatment group at 2 years.*
*Go to 🔗 link in bio to hear Dr. Costandi’s thoughts and view clinical data.
If you didn’t make it to #ASPN2024, you might’ve missed the latest MOTION Study data released by Dr. Tim Deer (@timdeer30a).
The new 3-year follow-up results of patients treated with Mild + conventional medical management provide additional evidence for the durability and safety of Mild as a first-line treatment in a real world setting for symptomatic LSS secondary to hypertrophic ligamentum flavum.*
*Check out Dr. Deer’s insights on the study and view the clinical data at the 🔗 link in bio.
Another fantastic society meeting for the history books!
Thank you to the American Society of Pain and Neuroscience (@aspn_painneuro) and all our Mild providers for making #ASPN2024 an interesting and educational meeting. We`re particularly thankful for all the moving Mild stories you shared with us and the new data we got to explore from the MOTION Study.
If you missed out on ASPN, visit the 🔗 link in bio for event highlights!
In a new case study from Dr. Youssef Josephson (@doctorjoedo) with Modern Spine and Pain, we’re sharing how the Mild Procedure helped an 87-year-old female patient with lumbar spinal stenosis patient (#LSS) avoid major surgery while improving quality of life, regaining functional ability, and discontinuing use of pain medication.
Read Dr. Josephson’s case study at the 🔗 link in bio.
Our CEO, Eric Wichems, had the honor of joining an #ASPN2024 panel discussion on “Explosive Innovation and Limited Patient Access in Minimally Invasive Spine: Fixing a Broken System.”
Thank you to the American Society of Pain and Neuroscience (@aspn_painneuro) for hosting this important talk and their advocacy for improved patient access!
Interested in resources to help increase patient access to Mild? Visit the 🔗 link in bio.
Thank you to everyone who attended our #ASPN2024 symposium on “A New Era for IPM: Elevate Your Practice & Your Community Through Mild.”
A special thanks to our fantastic panel of speakers: Dr. David M. Dickerson (@daviddickersonmd), Advanced Practice Provider Zohra Hussaini, Dr. Rebecca Sanders, and Dr. Peter Pryzbylkowski (@drpryz). We’re grateful to their dedication to the IPM community. We know that their insights and experiences will help many providers grow their practices, expand patient access, and enhance patient experience.
Click the 🔗 link in bio to stay up to date on Mild news and our ASPN 2024 activities.
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
The mild® Procedure is a minimally invasive treatment for lumbar spinal stenosis. As with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’ Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.
Mobility Matters: Low Back Pain in America, Harris Poll Survey, 2022. View data and full summary here.
Deer TR, Grider JS, Pope JE, et al. Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN). J Pain Res. 2022;15:1325-1354. Published 2022 May 5. doi:10.2147/JPR.S355285.
